Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.

Gastroenterology - 1 Dec 2006

Ménager-Marcq Ingrid, Pomié Céline, Romagnoli Paola, van Meerwijk Joost P M

Abstract excerpt

BACKGROUND & AIMS: Immune responses to innocuous intestinal antigens appear tightly controlled by regulatory T lymphocytes. While CD4+ T lymphocytes have recently attracted the most attention, CD8+ regulatory T-cell populations are also believed to play an important role in control of mucosal immunity. However, CD8+ regulatory T-cell function has mainly been studied in vitro and no direct in vivo evidence exists...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD28 Antigens
Share to CD8 Antigens
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammatory Bowel Diseases

Share to Interleukin-10

Share to Intestinal Mucosa

Share to Mice, Inbred DBA

Share to T-Lymphocytes, Regulatory

Source

Open in PubMed Open full text

Identifiers

PMID: 17087950
DOI: 10.1053/j.gastro.2006.09.008
PMCID: PMC1950262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.PMID 17087950Read ↗

Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.Semantic proximity Read ↗

Promises and paradoxes of regulatory T cells in inflammatory bowel disease.Semantic proximity Read ↗

Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.Semantic proximity Read ↗

Autoimmune regulator (AIRE)-deficient CD8+CD28low regulatory T lymphocytes fail to control experimental colitis.Semantic proximity Read ↗

The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.Semantic proximity Read ↗

Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function.Semantic proximity Read ↗

Impaired regulatory T cell function in germ-free mice.Semantic proximity Read ↗

Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitisSemantic proximity Read ↗

Phenotypically distinct subsets of CD4<sup>+</sup> T cells induce or protect from chronic intestinal inflammation in C. B-17 <i>scid</i> miceSemantic proximity Read ↗

CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.Semantic proximity Read ↗

CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in <i>ApcMin/+</i> MiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.